Patents by Inventor Losee Lucy Ling

Losee Lucy Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11891415
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: February 6, 2024
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11851458
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: December 26, 2023
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20220289793
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: October 13, 2021
    Publication date: September 15, 2022
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20220185845
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: November 11, 2021
    Publication date: June 16, 2022
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11203616
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: December 21, 2021
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11174290
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: November 16, 2021
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20210052693
    Abstract: The present invention provides pharmaceutical compositions of teixobactin that are capable of preventing gelation of teixobactin. The pharmaceutical compositions comprise teixobactin and a pegylated phospholipid. The present invention also provides methods of preparing the pharmaceutical compositions of teixobactin and methods of treating a subject using the pharmaceutical compositions of teixobactin.
    Type: Application
    Filed: February 6, 2019
    Publication date: February 25, 2021
    Inventors: Ana Cristina Cadete Pires, Aranda Rae Duan, Losee Lucy Ling
  • Publication number: 20200031871
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: March 30, 2018
    Publication date: January 30, 2020
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Publication number: 20200024310
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: August 1, 2019
    Publication date: January 23, 2020
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 10414800
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: September 17, 2019
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20170121372
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: June 15, 2016
    Publication date: May 4, 2017
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20160311835
    Abstract: The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.
    Type: Application
    Filed: November 30, 2015
    Publication date: October 27, 2016
    Inventors: Aaron Peoples, Losee Lucy Ling, Kim Lewis, Slava S. Epstein
  • Patent number: 9402878
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: August 2, 2016
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20150313960
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: July 1, 2015
    Publication date: November 5, 2015
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 9163065
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: October 20, 2015
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20140194345
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: December 3, 2013
    Publication date: July 10, 2014
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullenec, Kim Lewis
  • Publication number: 20120302613
    Abstract: The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 29, 2012
    Applicant: NOVOBIOTIC PHARMACEUTICALS LLC
    Inventors: Aaron PEOPLES, Losee Lucy LING, Kim LEWIS, Slava S. EPSTEIN
  • Publication number: 20090156514
    Abstract: The invention relates generally to novel macrolactams and their analogs, to processes for the preparation of these novel macrolactams, to pharmaceutical compositions comprising the novel macrolactams; and to methods of using the novel macrolactams to treat or inhibit various disorders.
    Type: Application
    Filed: August 22, 2008
    Publication date: June 18, 2009
    Applicant: NovoBiotic Pharmaceuticals LLC
    Inventors: Aaron PEOPLES, Qibo ZHANG, Charles MOORE, Losee Lucy LING, Mithra ROTHFEDER, Kim Lewis
  • Publication number: 20030108872
    Abstract: The invention relates to methods and systems of determining targets of compounds and compositions, as well as a high through-put method of screening antimicrobial agents. The methods involve (i) the prediction of a target using two and preferably at least three different submethods, (ii) identifying the gene encoding the target by each of these submethods, (iii) analysing the potential targets of each submethod to predict the putative target, and (iv) validating the target and the drug which perturbs it.
    Type: Application
    Filed: August 23, 2001
    Publication date: June 12, 2003
    Inventors: Mark Sulavik, Losee Lucy Ling, Tim Opperman, Donald T. Moir, Christopher Bunker